Prophylactic Treatment with Paroxetine Ameliorates Behavioral Deficits and Retards the Development of Amyloid and Tau Pathologies in 3xTgAD Mice

A history of depression is a risk factor for Alzheimer’s disease (AD), suggesting the possibility that antidepressants administered prophylactically might retard the disease process and preserve cognitive function. Here we report that pre-symptomatic treatment with the antidepressant paroxetine atte...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Nelson, Rhonda L., Guo, Zhihong, Halagappa, Veerendra Madala, Pearson, Michelle, Gray, Audrey J., Matsuoka, Yasuji, Brown, Martin, Clark, Robert F., Mattson, Mark P.
Format: Artigo
Jezik:Inglês
Izdano: 2007
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1979096/
https://ncbi.nlm.nih.gov/pubmed/17368447
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.expneurol.2007.01.037
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items